373 related articles for article (PubMed ID: 9574878)
1. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis.
Svensson C; Andersson M; Greiff L; Blychert LO; Persson CG
Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.
Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C
Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis.
Svensson C; Klementsson H; Andersson M; Pipkorn U; Alkner U; Persson CG
Allergy; 1994 Mar; 49(3):177-83. PubMed ID: 8198250
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. FLNCO2 Italian Study Group.
Ortolani C; Foresi A; Di Lorenzo G; Bagnato G; Bonifazi F; Crimi N; Emmi L; Prandini M; Senna GE; Tursi A; Mirone C; Leone C; Fina P; Testi R
Allergy; 1999 Nov; 54(11):1173-80. PubMed ID: 10604553
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis: levocabastine effect.
Bernardini R; Novembre E; Mugnaini L; Rossi ME; Vierucci A
Allergy Asthma Proc; 1998; 19(2):75-80. PubMed ID: 9578915
[TBL] [Abstract][Full Text] [Related]
7. Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions.
Corren J; Rachelefsky G; Spector S; Schanker H; Siegel S; Holton D; Karcher K; Travers S
J Allergy Clin Immunol; 1999 Apr; 103(4):574-80. PubMed ID: 10200003
[TBL] [Abstract][Full Text] [Related]
8. Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge.
Erin EM; Leaker BR; Zacharasiewicz AS; Higgins LA; Williams TJ; Boyce MJ; de Boer P; Durham SR; Barnes PJ; Hansel TT
Allergy; 2005 Dec; 60(12):1524-9. PubMed ID: 16266385
[TBL] [Abstract][Full Text] [Related]
9. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
[TBL] [Abstract][Full Text] [Related]
10. Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.
Meyer P; Andersson M; Persson CG; Greiff L
Pediatr Allergy Immunol; 2003 Feb; 14(1):60-5. PubMed ID: 12603713
[TBL] [Abstract][Full Text] [Related]
11. Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis.
Ahlström Emanuelsson C; Andersson M; Persson CG; Thorsson L; Greiff L
Respir Med; 2007 Jun; 101(6):1106-12. PubMed ID: 17215115
[TBL] [Abstract][Full Text] [Related]
12. Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5.
Linden M; Svensson C; Andersson E; Andersson M; Greiff L; Persson CG
Am J Respir Crit Care Med; 2000 Nov; 162(5):1705-8. PubMed ID: 11069800
[TBL] [Abstract][Full Text] [Related]
13. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
Greiff L; Persson CG; Andersson M
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
[TBL] [Abstract][Full Text] [Related]
14. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
[TBL] [Abstract][Full Text] [Related]
15. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
[TBL] [Abstract][Full Text] [Related]
16. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
Bende M; Pipkorn U
Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
[TBL] [Abstract][Full Text] [Related]
17. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
Greiff L; Petersen H; Mattsson E; Andersson M; Erjefält JS; Linden M; Svensson C; Persson CG
Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
[TBL] [Abstract][Full Text] [Related]
18. Effects of orally inhaled budesonide in seasonal allergic rhinitis.
Greiff L; Andersson M; Svensson C; Linden M; Wollmer P; Brattsand R; Persson CG
Eur Respir J; 1998 Jun; 11(6):1268-73. PubMed ID: 9657565
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model.
Andersson M; Svensson C; Persson C; Akerlund A; Greiff L
Ann Allergy Asthma Immunol; 2000 Oct; 85(4):279-83. PubMed ID: 11061470
[TBL] [Abstract][Full Text] [Related]
20. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
Bachert C; Wagenmann M; Vossen-Holzenkamp S
Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
